Amphiphilic block copolymers for drug delivery

Journal of Pharmaceutical Sciences

Volumn 92, Issue 7, 2003, Pages 1343-1355

  Adams, Monica L ^a   Lavasanifar, Afsaneh ^b   Kwon, Glen S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Drug delivery; PEG; Polymer; Polymeric micelles; Solubilization

Indexed keywords

6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE; AMPHOTERICIN B; ANDROSTANOLONE; CISPLATIN; CLONAZEPAM; COPOLYMER; DAUNORUBICIN; DIGOXIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUORESCEIN; INDOMETACIN; LOPERAMIDE; LYSOZYME; MACROGOL; METHOTREXATE; MITOMYCIN C; NIMODIPINE; NYSTATIN; OLIGODEOXYNUCLEOTIDE; PACLITAXEL; POLOXAMER; POLYPROPYLENE; PYRENE; RHODAMINE 123; RUBOXYL; TACROLIMUS; VALPROIC ACID; ZIDOVUDINE;

AQUEOUS SOLUTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; HYDROPHOBICITY; MICELLE; SHORT SURVEY; SOLUBILIZATION; SUSTAINED RELEASE PREPARATION;

EID: 0038759662     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10397     Document Type: Short Survey

References (88)

1. Davis SS, Illum L. 1998. Drug delivery systems for challenging molecules. Int J Pharm 176:1-8.
2. Jones M-C, Leroux J-C. 1999. Polymeric micelles: A new generation of colloidal drug carriers. Eur J Pharm Biopharm 48:101-111.
3. Rosler A, Vandermeulen GW, Klok H-A. 2001. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev 53:95-108.
4. Kataoka K, Kwon G, Yokoyama M, Okano T, Sakurai Y. 1992. Block copolymer micelles as vehicles for drug delivery. J Control Release 24: 119-132.
5. Kwon G, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K. 1993. Micelles based on ab block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate). Langmuir 9:945-949.
6. Kim SY, Shin IG, Lee YM, Cho CS, Sung YK. 1998. Methoxy poly(ethylene glycol) and ε-caprolactone amphiphilic block copolymeric micelles containing indomethacin. II. Micelle formation and drug release behaviours. J Control Release 51:13-22.
7. Myers D. 1999. Association colloids: Micelles, vesicles, and membranes. In: Myers D, editor. Surfaces, interfaces, and colloids: Principles and applications, 2nd ed. New York: John Wiley & Sons, p 383.
8. Goon P, Manohar C, Kumar VV. 1997. Determination of critical micelles concentration of anionic surfactants: Comparison of internal and external fluorescent probes. J Colloid Interface Sci 189:177-180.
9. Yokoyama M, Sugiyama T, Okano T, Sakurai Y, Naito M, Kataoka K. 1993. Analysis of micelle formation of an adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm Res 10: 895-899.
10. Halperin A, Alexander S. 1989. Polymeric micelles: Their relaxation kinetics. Macromolecules 22: 2403-2412.
11. Wang P, Tan KL, Kang ET. 2000. Surface modification of poly(tetrafluoroethylene) films via grafting of poly(ethylene oxide) for reduction in protein adsorption. J Biomater Sci Polym Ed 11:169-186.
12. Zhang F, Kang ET, Neoh KG, Huang W. 2001. Modification of gold surface by grafting of poly(ethylene glycol) for reduction in protein adsorption and platelet adhesion. J Biomater Sci Polym Ed 12:515-531.
13. Lee JH, Lee HB, Andrade JD. 1995. Blood compatibility of polyethylene oxide surfaces. Prog Polym Sci 20:1043-1079.
14. Trubetskoy VS, Torchilin VP. 1995. Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents. Adv Drug Deliv Rev 16:311-320.
15. Zalipsky S, Harris JM. 1997. Introduction to chemistry and biological applications of poly(ethylene glycol). In: Harris JM, Zalipsky S, editors. Poly(ethylene glycol) chemistry and biological applications, ACS symposium series 680. Washington, DC: American Chemical Society, pp 1-13.
16. Working PK, Newman MS, Johnson J, Cornacoff JB. 1997. Safety of poly(ethylene glycol) and poly(ethylene glycol) derivatives. In: Harris JM, Zalipsky S, editors. Poly(ethylene glycol) chemistry and biological applications, ACS symposium series 680. Washington, DC: American Chemical Society, pp 45-57.
17. Jeon SI, Lee JH, Andrade JD, De Gennes PG. 1991. Protein-surface interactions in the presence of polyethylene oxide. I. Simplified theory. J Colloid Interface Sci 142:149-158.
18. Kwon GS, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka K. 1994. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Control Release 29: 17-23.
19. Yokoyama M, Okano T, Sakurai Y, Ekimoto H, Skibazaki C, Kataoka K. 1991. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res 51: 3229-3236.
20. Taillefer J, Jones M-C, Brasseur N, Van Lier JE, Leroux J-C. 2000. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drug. J Pharm Sci 89:52-62.
21. Torchilin VP, Levchenko TS, Whiteman KR, Yaroslavov AA, Tsatsakis AM, Rizos AK, Michailova EV, Shtilman MI. 2001. Amphiphilic poly-N-vinylpyrrolidones: Synthesis, properties, and liposome surface modification. Biomaterials 22: 3035-3044.
22. Stepanek M, Podhajecka K, Tesarova E, Prochazka K. 2001. Hybrid polymeric micelles with hydrophobic cores and mixed polyelectrolyte/nonelectrolyte shells in aqueous media. I. Preparation and basic characterization. Langmuir 17:4240-4244.
23. Roux E, Stomp R, Giasson S, Pezolet M, Moreau P, Leroux J-C. 2002. Steric stabilization of liposomes by pH-responsive N-isopropylacrylamide copolymer. J Pharm Sci 91:1795-1802.
24. Moghimi SM, Hunter AC, Murray JC. 2001. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 53:283-318.
25. Delgado C, Francis GE, Fisher D. 1992. The uses and properties of PEG-linked proteins. Crit Rev Ther Drug Carrier Syst 9:249-304.
26. Yamamoto Y, Yasugi K, Harada A, Nagasaki Y, Kataoka K. 2002. Temperature-related change in the properties relevant to drug delivery of poly (ethylene glycol)-poly(D,L-lactide) block copolymer micelles in aqueous milieu. J Control Release 82: 359-371.
27. Adams ML, Kwon GS. 2003. Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly (N-hexyl-L-aspartamide)-acyl conjugate micelles: Effects of acyl chain length. J Control Release 87:23-32.
28. Lavasanifar A, Samuel J, Kwon GS. 2002. The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide). J Control Release 79:165-172.
29. Maeda H, Wu J, Sawa T, Matsumara Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 65:271-284.
30. Maeda H, Sawa T, Konno T. 2001. Mechanism of tumor-targeted delivery of macromolecular drug, including the EPR effect in solid tumor and clinical overview off the prototype drug SMANCS. J Control Release 74:47-61.
31. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK. 1999. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci 95:4607-4612.
32. Yuan F, Leunig M, Haung SK, Berk DA, Papahadjopoulos D, Jain RK. 1994. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54:3352-3356.
33. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. 1995. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 55:3752-3756.
34. Alakhov VY, Moskaleva EY, Batrakova EV, Kabanov AV. 1996. Hypersensitization of multi-drug resistant human ovarian carcinoma cells by Pluronic P85 copolymer. Bioconjug Chem 7:209-216.
35. Yokoyama M, Satoh A, Sakurai Y, Okano T, Matsumura Y, Kakizoe T, Kataoka K. 1998. Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size. J Control Release 55:219-229.
36. Allen C, Han J, Yu Y, Maysinger D, Eisenberg A. 2000. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. J Control Release 63:275-286.
37. La SB, Okano T, Kataoka K. 1996. Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 85:85-90.
38. Li Y, Kwon GS. 2000. Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-Laspartamide). I. Effects of the level of methotrexate conjugation on the stability of micelles and on drug release. Pharm Res 17:607-611.
39. Nishiyama N, Kataoka K. 2001. Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum (II) in the core. J Control Release 74:83-94.
40. Lavasanifar A, Samuel J, Kwon GS. 2001. Micelles self-assembled from poly(ethylene oxide)-blockpoly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: Effect on the solubilization and haemolytic activity of amphotericin B. J Control Release 77:155-160.
41. Batrakova EV, Miller DW, Li S, Alakhov VY, Kabanov AV, Elmquist WF. 2001. Pluronic P85 enhanced the delivery of digoxin to the brain: In vitro and in vivo studies. J Pharmacol Exp Ther 296:551-557.
42. Adams ML, Kwon GS. 2002. The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugates. J Biomater Sci Polym Ed 13:991-1006.
43. Jeong Y-I, Cheon J-B, Kim S-H, Nah J-W, Lee Y-M, Sung Y-K, Akaike T, Cho C-S. 1998. Clonazepam release from core-shell type nanoparticles in vitro. J Control Release 51:169-178.
44. Yu BG, Okano T, Kataoka K, Sardari S, Kwon GS. 1998. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethyleneoxide)-block-poly(β-benzyl-L-aspartate) micelles. J Control Release 56:285-291.
45. Kwon GS, Naito M, Kataoka K, Yokoyama M, Sakurai Y, Okano T. 1994. Block copolymer micelles as vehicles for hydrophobic drugs. Colloids Surf B Biointerfaces 2:429-434.
46. Kataoka K, Matsumoto T, Yokoyama M, Okano T, Sakurai Y, Fukushima S, Okamoto K, Kwon GS. 2000. Doxorubicin-loaded poly(ethylene glycol)poly(β-benzyl-L-aspartate) copolymer micelles: Their pharmaceutical characteristics and biological significance. J Control Release 64:143-153.
47. Yokoyama M, Okano T, Sakurai Y, Kataoka K. 1994. Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Control Release 32:269-277.
48. Yokoyama M, Fukushima S, Uehara R, Okamoto K, Kataoka K, Sakurai Y, Okano T. 1998. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and their design for in vivo delivery to a solid tumor. J Control Release 50:79-92.
49. Harada A, Kataoka K. 1999. Chain length recognition: Core-shell supramolecular assembly from oppositely charged block copolymers. Science 283: 65-67.
50. Harada A, Togawa H, Kataoka K. 2001. Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. Eur J Pharm Sci 13:35-42.
51. Harada A, Kataoka K. 2001. Pronounced activity of enzymes through the incorporation into the core polyion complex micelles made from charged block copolymers. J Control Release 72:85-91.
52. Mannisto M, Vanderkerken S, Toncheva V, Elomaa M, Ruponen M, Schacht E, Urtti A. 2002. Structure-activity relationships of poly(L-lysines): Effects of PEGylation and molecular shape on physicochemical and biological properties in gene delivery. J Control Release 83:169-182.
53. Bogdanov AA Jr, Martin C, Bogdanova AV, Brady TJ, Weissleder R. 1996. An adduct of cis-diamminedichloroplatinum (II) and poly(ethylene glycol)-poly(L-lysine)-succinate: Synthesis and cytotoxic properties. Bioconjug Chem 7:144-149.
54. Matsumura Y. 2002. Phase I clinical trial of nk911, polymeric micelle encapsulated doxorubicin. In: Abstracts of the 2nd international symposium on tumor targeted delivery systems. Minneapolis, MN: Controlled Release Society, p 30.
55. Lavasanifar A, Samuel J, Kwon GS. 2002. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv Drug Deliv Rev 54:169-190.
56. Anseth KS, Metters AT, Bryant SJ, Martens PJ, Elisseeff JH, Bowman CN. 2002. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release 78:199-209.
57. Wu XS, Wang N. 2001. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic-glycolic acid polymers. II. Biodegradation. J Biomater Sci Polym Ed 12: 21-24.
58. Shin IG, Kim SY, Lee YM, Cho CS, Sung YK. 1998. Methoxy poly(ethylene glycol)/ε-caprolactone amphiphilic block copolymeric micelles containing indomethacin. I. Preparation and characterization. J Control Release 51:1-11.
59. Allen C, Yu Y, Maysinger D, Eisenberg A. 1998. Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconjug Chem 9:564-572.
60. Ge H, Hu Y, Jiang X, Cheng D, Yuan Y, Bi H, Yang C. 2002. Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly (ε-caprolactone-poly(ethylene oxide)-poly(ε-caprolactone) amphiphilic triblock copolymer micelles. J Pharm Sci 91:1463-1473.
61. Park YJ, Lee JY, Chang YS, Jeong JM, Chung JK, Lee MC, Park KB, Lee SJ. 2002. Radioisotope carrying polyethylene oxide-polycaprolactone copolymer micelles for targetable bone imaging. Biomaterials 23:873-879.
62. Stolnik S, Heald CR, Neal J, Garnett MC, Davis SS, Illum L, Purkis SD, Barlow RJ, Gellert PR. 2001. Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: Production, colloidal properties, and biological performance. J Drug Target 9:361-378.
63. Burt HM, Zhang X, Toleikis P, Embree L, Hunter WL. 1999. Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf B Biointerfaces 16:161-171.
64. Zhang X, Jackson JK, Burt HM. 1996. Development of copolymers as micellar carriers of Taxol. Int J Pharm 132:195-206.
65. Liggins RT, Burt HM. 2002. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 54:191-202.
66. Yamamoto Y, Nagasaki Y, Kato M, Kataoka K. 1999. Surface charge modulation of poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles: Conjugation of charged peptides. Colloid Surf B Biointerfaces 16:135-146.
67. Yasugi K, Nakamura T, Nagasaki Y, Kato M, Kataoka K. 1999. Sugar-installed polymer micelles: Synthesis and micellization of poly(ethylene glycol)poly(D,L-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 32:8024-8032.
68. Nagasaki Y, Yasugi K, Yamamoto Y, Harada A, Kataoka K. 2001. Sugar-installed block copolymer micelles: Their preparation and specific interaction with lectin molecules. Biomacromolecules 2:1067-1070.
69. Yoo HS, Park TG. 2001. Biodegradable polymeric micelles composed of doxorubicin conjugate PLGA-PEG block copolymer. J Control Release 70: 63-70.
70. Jeong B, Bae YH, Kim SW. 1999. Biodegradable thermosensitive micelles of PEG-PLGA-PEG tri-block copolymers. Colloid Surf B Biointerfaces 16:185-193.
71. Jeong B, Lee KM, Gutowska A, An YH. 2002. Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. Biomacromolecules 3:865-868.
72. Kissel T, Li Y, Unger F. 2002. ABA-triblock copolymers from biodegradable polyester A-block and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv Drug Deliv Rev 54:99-134.
73. Liu L, Li C, Li X, Yuan Z, An Y, He B. 2001. Biodegradable polylactide/poly(ethylene glycol)/ polylactide triblock copolymer micelles as anticancer drug carriers. J Appl Polym Sci 80:1976-1982.
74. Kozlov MY, Melik-Nubarov NS, Batrakova EV, Kabanov AV. 2000. Relationship between Pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes. Macromolecules 33:3305-3313.
75. Venne A, Li S, Madeville R, Kabanov A, Alakhov V. 1996. Hypersensitizing effect of Pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res 56:3626-3629.
76. Krishna R, Mayer LD. 2000. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokineties of anticancer drugs. Eur J Pharm Sci 11:265-283.
77. Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. 1999. Fundamental relationship between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res 16:1373-1379.
78. Batrakova EV, Li S, Elmquist WF, Miller DW, Alakhov VY, Kabanov AV. 2001. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer 85:1987-1997.
79. Pardridge WM. 1995. Preface: Overview of brain drug delivery. Adv Drug Deliv Rev 15:1-3.
80. Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV. 2001. Mechanism of Pluronic effect on P-glycoprotein efflux system in blood-brain barrier: Contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther 299:483-493.
81. Batrakova EV, Li S, Miller DW, Kabanov AV. 1999. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm Res 16:1366-1372.
82. Rapaport NY, Herron JN, Pitt WG, Pitina L. 1999. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: Effect of micelle structure and ultrasound on the intracellular drug uptake. J Control Release 58:153-162.
83. Marin A, Muniruzzaman MD, Rapoport N. 2001. Acoustic activation of drug delivery from polymeric micelles: Effect of pulsed ultrasound. J Control Release 71:239-249.
84. Marin A, Sun H, Husseini GA, Pitt WG, Christensen DA, Rapoport NY. 2002. Drug delivery in Pluronic micelles: Effect of high-frequency ultrasound on drug release from micelles and intracellular uptake. J Control Release 84:39-47.
85. Wei G, Xu H, Ding PT, Li SM, Zheng JM. 2002. Thermosetting gels with modulated gelation temperature for ophthalmic use: The rheological and gamma scintigraphic studies. J Control Release 83:65-74.
86. Yu B, Nichols BC, Aramwit P, Kwon G. 2000. The effect of Pluronics® F127 and F68 on the aggregation state and hemolytic activity of nystatin. In: Park KD, Kwon IC, Yui N, Jeong SY, Park K, editors. Biomaterials and drug delivery toward new millennium. Seoul: Han Rim Won Publishing, pp 373-381.
87. Kabanov AV, Lemieux P, Vinogradov S, Alakhov V. 2002. Pluronic block copolymers: Novel functional molecules for gene therapy. Adv Drug Deliv Rev 54: 223-233.
88. Kabanov AV, Batrakova EV, Alakhov VY. 2002. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 82:189-212.